Nonresectional regional therapies for metastatic colorectal cancer to the liver

J Surg Oncol. 2019 Apr;119(5):636-641. doi: 10.1002/jso.25423. Epub 2019 Mar 1.

Abstract

The liver is the second leading site of colorectal cancer metastases, following the lymph nodes. Although metastatic resection for colorectal cancer liver metastases has been shown to improve survival, many patients cannot undergo surgery. Several nonsurgical therapies are available in these situations, however high-quality evidence comparing the effectiveness of these therapies is sparse. Here, we review the currently available evidence in support of nonresectional regional therapies for colorectal metastases to the liver.

Keywords: colorectal cancer; hepatic metastases; liver-directed therapy; metastatic colorectal cancer; regional therapies.

Publication types

  • Review

MeSH terms

  • Ablation Techniques
  • Chemoembolization, Therapeutic
  • Colorectal Neoplasms / pathology*
  • Hepatic Artery
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy*